Dr. Andrew Kennedy, co-medical director for Wake Radiology Oncology Services in Cary, is an internationally acclaimed radiation oncologist specializing in gastrointestinal cancers, as well as cancers of the breast, lung and cervix. He has given numerous presentations on radiation therapy for the treatment of colorectal and liver cancer, and was instrumental in reintroducing an important new treatment for liver cancer, called infusion of microspheres, which offers hope to patients who have not had success with chemotherapy.

Dr. Kennedy developed the most commonly used protocol in the US for infusion of microspheres and is the recipient of more than $860,000 in research grants to further investigate this and other cancer treatments.

Dr. Kennedy has also received grants from the University of Maryland School of Medicine to study a new treatment for lung cancer.

He has written dozens of articles, book chapters and abstracts on radiation oncology and has been invited to give presentations on radiation therapy for GI cancers and infusion of microspheres at the premier medical conferences in the United States and Europe. He is the primary instructor of other radiation oncologists of microsphere therapy in the world.

Dr. Kennedy is a graduate of Loma Linda School of Medicine, in Loma Linda, California, and completed his residency at The University of North Carolina at Chapel Hill. As chief resident, and later a research fellow, he completed significant work in three-dimensional treatment planning (3D external beam radiation therapy) and radiobiology research.

He was an associate professor in the Radiation Oncology and head of GI radiation oncology at The University of Maryland School of Medicine, and Residency program director from 1997-2002.

He joined the team at Wake Radiology in 2002, where his primary concern continues to be offering his patients the best and latest treatments for cancer in a supportive, compassionate setting.

Dr. Scott Lee Sailer is one of the nation’s leading radiation oncologists and as co-medical director of Wake Radiology’s Cary Oncology Center, brings an outstanding breadth of experience treating a variety of cancers, including cancer of the head, neck, and prostate.

Dr. Sailer is also at the forefront of several important new cancer treatments. He is one of the first radiation oncologists in North Carolina to offer MammoSite ®, a procedure that can reduce the time spent by breast cancer patients in radiation therapy from six weeks to one. And he will soon begin offering brachytherapy treatment for prostate cancer.

His dedication to the development of effective new treatments has brought national acclaim and such well-earned accolades as being named one of “America’s Top Doctors,” by Castle Connolly Medical, Ltd. He was also honored by his peers when asked to be an examiner of new radiologists by the American College of Radiology.

Dr. Sailer has studied, taught and practiced medicine at two of the leading radiation oncology programs in the country.

After graduating from the Harvard Medical School, Dr. Sailer was appointed Chief Resident in Radiation Therapy in the Department of Radiation Medicine at Massachusetts General Hospital in Boston. In 1988, he moved to North Carolina to join the radiation therapy staff at UNC Hospitals in Chapel Hill. There he worked as an associate professor, clinical researcher and, most recently, was Medical Director of the Radiation Therapy Program.

While on staff at Chapel Hill, Dr. Sailer played a key role in the early clinical use of Intensity Modulated Radiation Therapy (IMRT), a major advance in the treatment of head, neck and prostate cancers through radiation therapy. When combined with Three Dimensional Radiation Therapy, (also known as 3D treatment planning) IMRT can prevent unnecessary damage to healthy tissue by accurately focusing the most intense beams of radiation on the cancerous cells.

Dr. Sailer has written over 20 articles and abstracts related to cancer treatment and has given numerous presentations. In addition, he is the recipient of eight research grants from such groups as the American Cancer Society and the National Cancer Institute. And he has participated in or developed multiple clinical protocols, which investigated new forms of cancer treatment.

Although Dr. Sailer has a distinguished record as a clinician and scientist, he is possibly best known for his deep compassion for the well being of his patients. As co-medical director with Dr. Andrew Kennedy of Wake Radiology’s oncology clinic in Cary, Dr. Sailer is committed to the highest quality of treatment, and the best level of care possible, for all of his patients.